Top Markets
Coin of the day
Polydex Pharmaceuticals Limited Polydex Pharmaceuticals Limited

Polydex Pharmaceuticals Limited

POLXF
Classement en actions #33810
Polydex Pharmaceuticals Limited (PPL), a Toronto, Canada-based company, was... Polydex Pharmaceuticals Limited (PPL), a Toronto, Canada-based company, was incorporated in 1979 and initially operated as Polydex Chemicals Limited before adopting its current name in March 1984. PPL specializes in the research, development, manufacturing, and global marketing of biotechnology-derived products for the human pharmaceutical sector. Beyond its human health focus, PPL also produces vital pharmaceutical intermediates for the veterinary industry. Its core product line centers on dextran and its various derivatives. Notable examples include iron dextran, a compound administered to newborn pigs to combat anemia, and dextran sulphate, a specialized chemical derivative crucial for biotechnology applications and the broader pharmaceutical sector. Furthermore, the company is actively developing Ushercell, a high molecular weight cellulose sulphate. This innovative product is designed for topical vaginal use, primarily aimed at preventing the transmission of AIDS and other sexually transmitted diseases, as well as unplanned pregnancies. PPL's portfolio further extends to supplying ferric hydroxide and hydrogenated dextran solutions. Products reach the market through a combination of independent distributors, wholesalers, and direct sales channels to various companies.
Prix de l'action
$1.99
Dernière synchronisation: 2023-08-07
Capitalisation boursière
$6.82M
Changement (1 jour)
0.30%
Changement (1 an)
0.00%
Pays
CA
Échange Polydex Pharmaceuticals Limited (POLXF)

Catégorie

Le prix POLXF avec la capitalisation boursière de B
Polydex Pharmaceuticals Limited Polydex Pharmaceuticals Limited
POLXF
$1.99
Capitalisation boursière de Polydex Pharmaceuticals Limited(POLXF)
Capitalisation boursière: $6.82M
En August 2026, Polydex Pharmaceuticals Limited a une capitalisation boursière de $6.82M. Cela fait de Polydex Pharmaceuticals Limited la 33810th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Polydex Pharmaceuticals Limited du 1981 au 2026
POLXF par rapport au top 5 des plus populaires stocks
Prix pour POLXF L’actif B La capitalisation boursière de B Résultats
Polydex Pharmaceuticals Limited Polydex Pharmaceuticals Limited
$1,588,258 $6.82M
$5.452T +79,972,615.54%
Polydex Pharmaceuticals Limited Polydex Pharmaceuticals Limited
$1,308,049 $6.82M
$4.490T +65,863,402.81%
Polydex Pharmaceuticals Limited Polydex Pharmaceuticals Limited
$1,212,608 $6.82M
$4.162T +61,057,689.50%
Polydex Pharmaceuticals Limited Polydex Pharmaceuticals Limited
$1,071,006 $6.82M
$3.676T +53,927,673.47%
Polydex Pharmaceuticals Limited Polydex Pharmaceuticals Limited
$825,332 $6.82M
$2.833T +41,557,421.77%